C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2011
11/09/2011	CN102234314A Method for preparing a group of snake venom derived active peptides and application of active peptides in anti-tumor aspect
11/09/2011	CN101456902B Microorganism metabolites feed supplement cyclic decapeptide and application
11/09/2011	CN101270153B Cyclo-pentapeptide and synthesizing method
11/08/2011	US8053556 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
11/08/2011	US8053555 Carbon nanotube binding peptides
11/08/2011	US8053554 Peptide nanostructures and methods of generating and using the same
11/08/2011	US8053209 FRET protease assays for clostridial toxins
11/08/2011	US8053208 FRET protease assays for clostridial toxins
11/08/2011	US8052975 Compounds and methods for treatment and diagnosis of chlamydial infection
11/08/2011	CA2459230C Peptidic compounds selectively binding to p-selectin
11/08/2011	CA2343414C Fc receptor modulators and uses thereof
11/03/2011	WO2011136744A1 Eif4e binding peptides
11/03/2011	WO2011136361A1 Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
11/03/2011	WO2011135905A1 Lipid membrane structure
11/03/2011	WO2011135513A1 Process for obtaining bioactive peptide extracts by hydrolysis of whey protein by cynara cardunculus enzymes, aforementioned extracts and respective applications
11/03/2011	WO2011108008A3 Antibody for targeted induction of apoptosis, cdc and adcc mediated killing of cancer cells, tbl-cln1
11/03/2011	WO2011066285A3 Peptide-based treatment for neurodegenerative diseases
11/03/2011	WO2011047097A3 Inhibition of trem receptor signaling with peptide variants
11/03/2011	WO2011008863A8 Stereoisomer peptides and their polymer conjugates for hiv disease
11/03/2011	WO2004039831A3 Peptide nucleic acid probes for analysis of enterococcus faecium
11/03/2011	US20110269943 Radiolabeled annexins
11/03/2011	US20110269938 Amyloid-beta peptide crystal structure
11/03/2011	US20110269937 Conserved-Element Vaccines and Methods for Designing Conserved-Element Vaccines
11/03/2011	US20110269695 Novel anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
11/03/2011	US20110269694 Novel anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
11/03/2011	US20110269689 High penetration compositions and their applications
11/03/2011	US20110269687 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
11/03/2011	US20110269686 Cxcr4 antagonist and use thereof
11/03/2011	US20110269683 Receptor(sstr2)-selective somatostatin antagonists
11/03/2011	US20110269676 Bifunctional molecules for inactivating hiv and blocking hiv entry
11/03/2011	US20110269674 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
11/03/2011	US20110269231 Proteoglycan-binding peptides that modulate stem cell behavior
11/03/2011	US20110269161 Methods, Compositions and Kits for High Throughput Kinase Activity Screening Using Mass Spectrometry and Stable Isotopes
11/03/2011	US20110269155 Detecting Antigen Responsive Cells in a Sample
11/03/2011	US20110268768 Compositions and Methods for Treating Atherosclerosis
11/03/2011	US20110268758 Tuberculosis antigen detection assays and vaccines
11/03/2011	US20110268756 Modified amyloid beta peptide
11/03/2011	US20110268750 Chimeric polynucleotides and polypeptides enabling secretion of a polypeptide of interest in association with exosomes and use thereof for the production of immunogenic compositions
11/03/2011	US20110268748 NURR-1 Interacting Protein (NuIP)
11/03/2011	US20110268726 Anti-CD38 human antibodies and uses thereof
11/03/2011	US20110268695 Use of hmgb fragments as anti-inflammatory agents
11/03/2011	US20110268670 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/03/2011	CA2793715A1 Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
11/02/2011	EP2383336A1 Peptide capable of binding to immunoglobulin
11/02/2011	EP2383283A2 Noggin-derived peptide and use thereof
11/02/2011	EP2383282A1 Peptides for treatment of the human papillomavirus (HPV)-associated cancer and other epithelial tumors
11/02/2011	EP2383281A2 Prion-specific peptoid reagents
11/02/2011	EP2382996A2 Lipid Film Structure Containing a Polyoxyalkylene Chain-Containing Lipid Derivative.
11/02/2011	EP2382314A1 C1orf59 peptides and vaccines including the same
11/02/2011	EP1734971B1 Polymer-based sustained release device
11/02/2011	EP1730110B9 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
11/02/2011	EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
11/02/2011	CN102232083A 禽流感疫苗 Bird flu vaccine
11/02/2011	CN102232082A A nonapeptide with anti-tumour activity
11/02/2011	CN102229659A Rana nigromaculata antibacterial peptide and gene and application thereof
11/02/2011	CN102229658A Anti-rheumatoid arthritis polypeptide and its application in pharmacy
11/02/2011	CN102229657A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229656A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229655A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229654A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229653A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229652A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229651A Amyloid protein intra-membrane segment for treating Alzheimer disease and application thereof
11/02/2011	CN102229650A High purity lipopeptides, lipopeptide micelles and processes for preparing same
11/02/2011	CN102229649A Preparation method of body protection polypeptide (BPC 157 peptide)
11/02/2011	CN102229648A HLA-A*0201 restrictive CTL (cytotoxic T lymphocyte) epitope for tumor antigen Pokemon and application thereof
11/02/2011	CN102229647A Amino acid sequence of synovium-derived mesenchymal stem cell affinity peptide, screening method and application
11/02/2011	CN102229646A Amino acid sequence of bone marrow mesenchymal stem cell affinity peptide, screening method and application
11/02/2011	CN102229645A Method for preparing immune seven peptides
11/02/2011	CN101230090B Blood peptide X and derivative thereof as well as preparation method and use thereof
11/01/2011	US8048984 Human GIL-19/AE289 proteins
11/01/2011	US8048858 Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions
11/01/2011	US8048852 Antimicrobial compounds and formulations
11/01/2011	US8048643 FRET protease assays for clostridial toxins
11/01/2011	CA2494140C Specific antibodies for diagnosing heart failure
11/01/2011	CA2221192C Embedded expression of heterologous proteins
10/2011
10/27/2011	WO2011133555A2 Compositions and methods for inhibiting matrix metalloproteinase (mmp)-mediated cell migration
10/27/2011	WO2011133112A1 Cell penetrating peptide derived from the premembrane protein of flavivirus
10/27/2011	WO2011131896A2 Peptide derivatives, preparation thereof and uses thereof as vectors
10/27/2011	WO2011131735A1 Cyclopentapeptide derivatives and uses thereof
10/27/2011	WO2011131731A1 Cyclopeptide derivatives and uses thereof
10/27/2011	WO2011130858A1 Method for the identification of t cell epitopes
10/27/2011	WO2011069227A8 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
10/27/2011	WO2011038149A3 Methods of treating inflammation
10/27/2011	WO2010133367A3 Novel solid materials of {[2s, 5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them
10/27/2011	US20110263818 Peptidic Constructs with Amino Acid Surrogates
10/27/2011	US20110263817 Metal-binding compounds and uses therefor
10/27/2011	US20110263816 Metallopeptide catalysts
10/27/2011	US20110263517 Cytokines and Cytokine Receptors with Reduced Immunogenicity
10/27/2011	US20110263515 Capture agents and related compositions, methods and systems
10/27/2011	US20110263511 Tight junction protein modulators and uses thereof
10/27/2011	US20110263505 Whey Protein Hydrolysate Containing Tryptophan Peptide Consisting of Alpha Lactalbumin and the Use Thereof
10/27/2011	US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011	US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011	US20110262529 Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
10/27/2011	US20110262508 Antimicrobial compositions, formulations and uses thereof
10/27/2011	US20110262475 Lyme disease vaccine
10/27/2011	US20110262400 Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
10/27/2011	US20110262366 Compounds for targeting endothelial cells, compositions containing the same and methods for their use
10/27/2011	US20110262358 Molecular marker for cancer stem cell

1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 423